Netarsudil: A new ophthalmic drug in the treatment of chronic primary open angle glaucoma and ocular hypertension.

Mansi BatraSumeet Gupta Anroop Balachandran NairMeenakshi DhanawatSuraj SandalMohamed Aly Morsy

Published in: European journal of ophthalmology (2021)

The discovery of netarsudil is a breakthrough in the therapy of glaucoma with proven efficacy in a wide range of eye pressures and is well tolerated in cases with ocular hypertension and chronic glaucoma.

Keyphrases

optic nerve
blood pressure
small molecule
drug induced
optical coherence tomography
emergency department
cataract surgery
mesenchymal stem cells
single cell
arterial hypertension
electronic health record